CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $2.04B, above the global median of $1.18B
- PositionP/E ratio is 494.08×, higher than 95% of its Medical Instruments & Supplies peers (median 38×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.07%
Annual Rate
CNY 0.05Paid annual
Payout Ratio
96.8%High
Last Ex-Dividend
Jul 16, 2026
The reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
13.69BCNY2.04B · vs all stocks (USD)
Trailing P/E
494.08xvs Medical Instruments & Supplies peers
Revenue (TTM)
608.73MCNY90.83M · vs all stocks (USD)
Profit Margin
3.96%vs Medical Instruments & Supplies peers
Beta
0.9340xvs all stocks
52-Week Change
132.94%vs all stocks
Market Capitalization
13.69BCNY2.04B · vs all stocks (USD)
Enterprise Value
12.58BCNY1.88B · vs all stocks (USD)
Trailing P/E
494.08xvs Medical Instruments & Supplies peers
Forward P/E
92.27xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
22.49xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
6.27xvs Medical Instruments & Supplies peers
Enterprise to Revenue
20.67xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
144.20xvs Medical Instruments & Supplies peers
Gross Margin
40.40%vs Medical Instruments & Supplies peers
Profit Margin
3.96%vs Medical Instruments & Supplies peers
Operating Margin
1.59%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.29%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.05%vs Medical Instruments & Supplies peers
Revenue (TTM)
608.73MCNY90.83M · vs all stocks (USD)
Revenue per Share (TTM)
3.05CNYUpdated Sep 21, 2026Quarterly Revenue Growth
3.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
233.08MCNY34.78M · vs all stocks (USD)
EBITDA (TTM)
133.14MCNY19.87M · vs all stocks (USD)
Net Income (TTM)
24.12MCNY3.60M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-72.10%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
89.29MCNY13.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-26.02MCNY-3.88M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.07%vs all stocks
Payout Ratio
96.76%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
4.17MCNYFY2025 · Dec 31, 2025Revenue
619.45MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
378.66MCNYFY2025 · Dec 31, 2025Gross Profit
240.79MCNYFY2025 · Dec 31, 2025Operating Income
57.49MCNY8.58M · vs all stocks (USD)
Pre-tax Income
69.13MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.27MCNYFY2025 · Dec 31, 2025Net Income
59.86MCNYFY2025 · Dec 31, 2025EBIT
70.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
133.14MCNYFY2025 · Dec 31, 2025Research & Development
39.51MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
68.89MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.53MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.09MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.35MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3670CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3670CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
163.97MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
163.97MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
59.86MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
311.88KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
43.14MCNYFY2025 · Dec 31, 2025Free Cash Flow
-88.73MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
338.06MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
59.86MCNYFY2025 · Dec 31, 2025Other Non-cash Items
14.07MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-29.12MCNYFY2025 · Dec 31, 2025Capital Expenditures
-131.86MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.49BCNYFY2025 · Dec 31, 2025Sale of Investments
3.49BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-138.76MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
126.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-40.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-26.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
-76.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-16.27MCNYFY2025 · Dec 31, 2025Shares Outstanding
213.16MSharesUpdated Sep 21, 2026Float Shares
143.41MSharesUpdated Sep 21, 2026% Held by Insiders
34.45%vs all stocks
% Held by Institutions
21.29%vs all stocks
Total Cash (MRQ)
1.24BCNY184.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.80CNYUpdated Sep 21, 2026Total Debt (MRQ)
133.99MCNY19.99M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0613xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
6.85xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
10.25CNYUpdated Sep 21, 2026Total Assets
2.55BCNY380.81M · vs all stocks (USD)
Total Current Assets
1.71BCNYFY2025 · Dec 31, 2025Total Liabilities
355.47MCNYFY2025 · Dec 31, 2025Total Non-current Assets
845.31MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
169.12MCNYFY2025 · Dec 31, 2025Total Current Liabilities
186.35MCNYFY2025 · Dec 31, 2025Cash
338.05MCNYFY2025 · Dec 31, 2025Cash Equivalents
16.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
354.16MCNYFY2025 · Dec 31, 2025Other Short-term Investments
845.32MCNYFY2025 · Dec 31, 2025Accounts Receivable
182.82MCNYFY2025 · Dec 31, 2025Inventory
154.14MCNYFY2025 · Dec 31, 2025Accounts Payable
112.83MCNYFY2025 · Dec 31, 2025Short-term Debt
7.41MCNYFY2025 · Dec 31, 2025Other Current Liabilities
196.23KCNYFY2025 · Dec 31, 2025Long-term Debt
83.33MCNYFY2025 · Dec 31, 2025Common Stock (Book)
164.20MCNYFY2025 · Dec 31, 2025Retained Earnings
454.08MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.20BCNY327.76M · vs all stocks (USD)
Treasury Stock
34.90MCNYFY2025 · Dec 31, 202552-Week Low
26.08CNYUpdated Sep 21, 202652-Week High
110.31CNYUpdated Sep 21, 202652-Week Change
132.94%vs all stocks
Beta
0.9340xvs all stocks
50-Day MA
69.21CNYUpdated Sep 21, 2026200-Day MA
68.32CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.75MSharesUpdated Sep 21, 2026Avg 30-Day Volume
5.90MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.1300CNYUpdated Sep 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 494.08×, higher than 95% of its Medical Instruments & Supplies peers (median 38×)Significant
P/E ratio: 494.077Industry median: 38.00Industry P95: 361.583Peers compared: 38.00
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 22.49Revenue Growth YoY: 0.03
High gross margins eroded by operating costsNotable
Gross Margin: 0.40Profit Margin: 0.04
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $2.04B, above the global median of $1.18BNotable
Market cap (USD): 2,042,736,459.142Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangzhou Risong Intelligent Technology Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shandong Hi-Tech Spring Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Awinic Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Changshu Tianyin Electromechanical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Ratnamani Metals & Tubes Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Roshine Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Zhejiang Weixing Industrial Development Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Whirlpool Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jilin OLED Material Tech Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Toyou Feiji Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Hesai Group
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Zhejiang Zhaolong Interconnect Co., Ltd.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Changzhou Zhongying Science & Technology Co., Ltd.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration